[Federal Register Volume 67, Number 85 (Thursday, May 2, 2002)]
[Notices]
[Pages 22085-22087]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-10833]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 02097]


Hemophilia Prevention Education and Peer Support; Notice of 
Availability of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2002 funds for a cooperative agreement 
program for Hemophilia Prevention Education and Peer Support. This 
program addresses the ``Healthy People 2010'' focus area(s) of 
Disability and Secondary Conditions, HIV, Immunization and Infectious 
Diseases, and Educational and Community-Based Programs.
    The purpose of the program is to enhance public health prevention 
practices for persons with bleeding disorders by: (1) Promoting peer-
led prevention education, intervention and outreach activities; (2) 
developing and implementing programs that educate and encourage persons 
with bleeding disorders to make informed decisions regarding healthcare 
practices and to adopt behaviors that reduce or eliminate bleeding 
disorder complications; (3) promoting the professional development of 
health care providers by encouraging collaboration between providers 
and persons with bleeding disorders to enhance prevention efforts; and 
(4) disseminating prevention and intervention information and education 
materials to the bleeding disorders community.

B. Eligible Applicants

    Applications may be submitted by public and private non-profit 
organizations and by governments and their agencies; that is, 
universities, colleges, research institutions, hospitals, other public 
and private non-profit organizations, State and local governments or 
their bona fide agents, including the District of Columbia, the 
Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of 
the Northern Mariana Islands, American Samoa, Guam, the Federated 
States of Micronesia, the Republic of the Marshall Islands, and the 
Republic of Palau, federally recognized Indian tribal governments, 
Indian tribes, or Indian tribal organizations. Faith-based 
organizations are eligible for this award.

    Note: Title II of the United States Code section 1611 states 
that an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant or loan.

C. Availability of Funds

    Approximately $2,800,000 is available in FY 2002 to fund one award. 
It is expected that the award will begin on or about September 30, 2002 
and will be made for a 12-month budget period within a project period 
of up to five years. The funding estimate may change.
    Continuation awards within an approved project period will be on 
the basis of satisfactory progress as evidenced by required reports and 
the availability of funds.

Funding Preference

    A funding preference may be given to the current recipient because 
they can demonstrate experience in conducting, developing, and 
evaluating peer led prevention interventions and national programs. 
They have effective and well-defined working relationships with 
partnering communities (including local consumer organizations and 
hemophilia treatment centers).

D. Program Requirements

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for the activities under 1. 
(Recipient Activities) and CDC will be responsible for the activities 
listed under 2. (CDC Activities).

1. Recipient Activities

    a. Collaborate with consumers and hemophilia care providers to 
develop user-centered educational programs and materials aimed at 
reducing or eliminating complications of bleeding disorders.
    b. Evaluate the effectiveness of education programs and materials, 
identify gaps, and propose strategies to improve the quality and 
availability of educational resources and prevention information.
    c. Develop strategies to increase collaboration between local 
community based organizations and hemophilia treatment centers (HTCs) 
to enhance prevention programs.
    d. Maintain a comprehensive information clearinghouse for consumers 
and hemophilia care providers to disseminate information on health 
promotion, and prevention of complications for persons with bleeding 
disorders.
    e. Coordinate a model demonstration project by developing education 
programs, communication strategies/methods, and outcome measures to 
deliver prevention messages aimed at helping individuals make informed 
decisions regarding their care and adapting behaviors to prevent the 
complications associated with bleeding disorders. This project should 
be evaluated by assessing outcome measures, and yield a data bank of 
effective programs that can be duplicated and disseminated for use in 
local settings.
    f. Expand and enhance peer-based prevention and educational 
activities by supporting programs at the local level. Provide technical 
assistance and financial support for program planning, development, 
implementation, and evaluation of public health education for local 
peer-led activities to deliver prevention messages.
    g. Provide opportunities for hemophilia care providers to receive 
prevention information and training. Collaborate with current 
hemophilia care providers to develop orientation training for new 
providers.
    h. Promote programs for early diagnosis and management of women 
with bleeding disorders.
    i. Collaborate with community-based hemophilia organizations to 
develop, implement, and evaluate outreach initiatives to increase 
access to healthcare and prevention services for under served groups 
with bleeding disorders.
    j. Encourage the use of appropriate safety precautions to prevent 
the transmission of blood borne pathogens. Participate in a formal 
communication network with CDC, and other Federal agencies to address 
blood safety and availability issues when necessary. Encourage people 
with bleeding disorders to participate in blood safety monitoring 
efforts.

2. CDC Activities

    a. Provide scientific and public health information regarding the 
prevention of complications of hemophilia, and other bleeding 
disorders. This includes reviewing educational and promotional 
materials developed by the proposed program.
    b. Provide consultation and technical assistance for program 
planning, development, implementation, and evaluation, which may 
include consulting with committees or working

[[Page 22086]]

groups whose operations may impact the proposed programs.
    c. Collaborate in the presentation, publication, and dissemination 
of information resulting from these activities.
    d. Facilitate provider involvement and collaboration in consumer-
based program activities between the recipient and the Regional HTC 
Programs.
    e. Assist in the development of a research protocol for 
Institutional Review Board (IRB) review by all cooperating institutions 
participating in the research project. The CDC IRB will review and 
approve the protocol initially and on at least an annual basis until 
the research project is completed.

E. Content

Letter of Intent (LOI)

    An LOI is optional for this program. The narrative should be no 
more than three single-spaced pages, printed on one side, with one-inch 
margins, and unreduced font. Your letter of intent will be used to 
enable CDC to plan for the review, and should include the following 
information (1) the Program Announcement Number 02097, (2) name and 
address of institution, and (3) name, address, and telephone number of 
contact person. Notification can be provided by facsimile, postal mail, 
or electronic mail (E-mail).

Applications

    Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Your application will be evaluated on the criteria 
listed, so it is important to follow them in laying out your program 
plan. The narrative should be no more than 25 double-spaced pages, 
printed on one side, with one-inch margins, and unreduced font.
    The application should include:
1. Understanding of the Project
    Describe the need for prevention information and education programs 
for the target population. Explain the basis for providing such 
programs, expected outcomes and the relevance to preventing 
complications, and promoting healthy behaviors among people with 
bleeding disorders.
2. Objectives
    Establish long-range (five year) and short-term (one year) 
objectives for programmatic plans. Objectives should be specific, 
measurable, time-phased and realistic.
3. Operational Plan
    Describe the methods by which the objectives will be achieved, 
including their sequence.
4. Evaluation Plan
    Describe the plans to monitor the progress of the program, as well 
to evaluate the outcomes of the proposed activities.
5. Program Management
    Describe the roles and responsibilities of all project staff in the 
proposed project. The description should include their titles, 
qualifications, and experience, as well as the percentage of time each 
will devote to the project, and the portions of their salaries to be 
paid by the cooperative agreement.
6. Collaboration with Local Organizations and HTCs
    Describe plans to include local organizations and HTCs in the 
program.
7. Budget
    A detailed first year's budget for the cooperative agreement with 
projections for the next four additional years.

F. Submission and Deadline

Letter of Intent (LOI)

    On or before June 15, 2002, submit the Letter of Intent to the 
Grants Management Specialist identified in the ``Where to Obtain 
Additional Information'' section of this announcement.

Application

    Submit the original and two copies of PHS 5161-1 (OMB Number 0920-
0428). Forms are available in the application kit and at the following 
Internet address: www.cdc.gov/od/pgo/forminfo.htm.
    On or before July 15, 2002, submit the application to: Technical 
Information Management--PA02097, Procurement and Grants Office, Centers 
for Disease Control and Prevention, 2920 Brandywine Rd. Room 3000, 
Atlanta, GA 30341-4146.
    Deadline: Applications shall be considered as meeting the deadline 
if they are received on or before the deadline date.
    Late: Applications which do not meet the criteria above will be 
returned to the applicant.

G. Evaluation Criteria

    Each application will be evaluated individually against the 
following criteria by an independent review group appointed by CDC.

1. Understanding of the Project (15 points)

    The extent to which the applicant understands the requirements, 
problems, objectives and complexities of the project.

2. Objectives (15 points)

    The degree to which the proposed objectives are clearly stated, 
realistic, time-phased, and related to the purpose of the project.

3. Operational Plan (Total 25 points)

    a. The extent to which the applicant provides a detailed plan of 
proposed activities which are likely to achieve each objective and 
overall program goals. The extent to which the applicant provides a 
reasonable and complete schedule for implementing activities of the 
program. (20 points)
    b. The degree to which the applicant has met the CDC Policy 
requirements regarding the inclusion of women, ethnic, and racial 
groups in the proposed research. This includes (1) The proposed plan 
for the inclusion of both sexes and racial and ethnic minority 
populations for appropriate representation; (2) The proposed 
justification when representation is limited or absent; (3) A statement 
as to whether the design of the study is adequate to measure 
differences when warranted; and (4) A statement as to whether the plans 
for recruitment and outreach for study participants include the process 
of establishing partnerships with community(ies) and recognition of 
mutual benefits. (5 points)

4. Evaluation Plan (15 points)

    The extent to which the proposed evaluation plan is detailed, 
addresses goals and objectives of the program, and will document the 
program process, effectiveness and outcome. The extent to which a 
feasible plan for reporting evaluation results and using evaluation 
information for programmatic decisions is present.

5. Program Management (25 total points)

    a. The extent to which the applicant proposes potentially effective 
collaborations with local organizations and HTCs. (15 points)
    b. The extent to which professional personnel proposed to be 
involved in this project are qualified, including evidence of past 
achievements appropriate to this project. (10 points)

6. Measures of Effectiveness (5 points)

    The extent to which the applicant provide Measures of Effectiveness 
that will demonstrate the accomplishment of

[[Page 22087]]

the various identified objectives of the grant. Are the measures 
objective/quantitative and do they adequately measure the intended 
outcome?

7. Budget (Not Scored)

    The extent to which the applicant provides a detailed budget and 
narrative justification consistent with stated objectives and planned 
program activities.

8. Human Subjects (Not Scored)

    Does the application adequately address the requirements of Title 
45 CFR part 46 for the protection of human subjects?

H. Other Requirements

Technical Reporting Requirements

    Provide CDC with original plus two copies of:
    1. Semiannual progress reports.
    2. Financial status report, no more than 90 days after the end of 
the budget period.
    3. Final financial report and performance report, no more than 90 
days after the end of the project period.
    Send all reports to the Grants Management Specialist identified in 
the ``Where to Obtain Additional Information'' section of this 
announcement.
    The following additional requirements are applicable to this 
program. For a complete description of each, see Attachment I of the 
announcement.

AR-1  Human Subjects Requirements
AR-2  Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-5  HIV Program Review Panel Requirements
AR-10  Smoke-Free Workplace Requirements
AR-11  Healthy People 2010
AR-12  Lobbying Restrictions
AR-15  Proof of Non-Profit Status

I. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under section 301(a) [42 U.S.C. 241(a)] 
and 317 (k)(2) [42 U.S.C. 247b(k)(2)] of the Public Health Service Act, 
as amended. The Catalog of Federal Domestic Assistance number is 93.283

J. Where To Obtain Additional Information

    This and other CDC announcements can be found on the CDC home page 
Internet address--http://www.cdc.gov. Click on ``Funding'' then 
``Grants and Cooperative Agreements.''
    If you have questions after reviewing the contents of all the 
documents, business management technical assistance may be obtained 
from: Merlin Williams, Grants Management Specialist, Acquisition and 
Assistance, Branch B, Procurement and Grants Office, Centers for 
Disease Control and Prevention, 2920 Brandywine Road, Room 3000, 
Mailstop K-75, Atlanta, GA 30341-4146, Telephone number: 770-488-2765, 
E-mail address: [email protected].
    For program technical assistance, contact: Sally Crudder, Acting 
Deputy Chief, Hematologic Diseases Branch, National Center for 
Infectious Diseases, Centers for Disease Control and Prevention, 1600 
Clifton Road, MS E64, Atlanta, Georgia 30333, Telephone number: 404-
371-5270 or 5903, E-mail address: [email protected].

    Dated: April 26, 2002.
Sandra R. Manning,
CGFM, Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 02-10833 Filed 5-1-02; 8:45 am]
BILLING CODE 4163-18-P